Biomarin Pharmaceutical (BMRN) Acquisitions (2009 - 2016)

Biomarin Pharmaceutical has disclosed Acquisitions across 5 years of filings, most recently posting $1.3 million for Q4 2016.

• Quarterly Acquisitions changed N/A year-over-year to $1.3 million in Q4 2016, while the trailing twelve-month figure through Dec 2017 was $1.3 million (changed 0.0% YoY) and the FY2016 annual result came in at $2.8 million, down 99.48% from the prior year.
• Acquisitions slipped to $1.3 million in Q4 2016, from $538.4 million in the prior quarter.
• Over five years, Acquisitions peaked at $538.4 million in Q1 2015 and troughed at $1.3 million in Q4 2016.
• A 3-year average of $183.2 million and a median of $9.9 million in 2013 frame the typical range for Acquisitions.